Abstract
Aberrant Ret kinase activity has been implicated in multiple carcinomas and disorders. Many strategies have been implemented to identify Ret kinase inhibitors. This review details current efforts to discover novel small molecule Ret kinase inhibitiors. Furthermore, we compile a comprehensive list of Ret kinase inhibitors and describe clinical results of advanced assets with Ret inhibitory activity.
Keywords: Ret kinase, protein tyrosine kinase inhibitors, thyroid cancer
Mini-Reviews in Medicinal Chemistry
Title: Current Review of Small Molecule Ret Kinase Inhibitors
Volume: 10 Issue: 2
Author(s): W.J. Zuercher, B.J. Turunen and K.E. Lackey
Affiliation:
Keywords: Ret kinase, protein tyrosine kinase inhibitors, thyroid cancer
Abstract: Aberrant Ret kinase activity has been implicated in multiple carcinomas and disorders. Many strategies have been implemented to identify Ret kinase inhibitors. This review details current efforts to discover novel small molecule Ret kinase inhibitiors. Furthermore, we compile a comprehensive list of Ret kinase inhibitors and describe clinical results of advanced assets with Ret inhibitory activity.
Export Options
About this article
Cite this article as:
Zuercher W.J., Turunen B.J. and Lackey K.E., Current Review of Small Molecule Ret Kinase Inhibitors, Mini-Reviews in Medicinal Chemistry 2010; 10 (2) . https://dx.doi.org/10.2174/138955710791185154
DOI https://dx.doi.org/10.2174/138955710791185154 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Normal Cytochrome c Oxidase Activity in Prion Protein Gene-Deficient Mice
Protein & Peptide Letters Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition Exploring Protein-Protein Interactions with Synthetic Peptide Arrays
Mini-Reviews in Organic Chemistry A Systemic Approach to Cancer Treatment: Tumor Cell Reprogramming Focused on Endocrine-Related Cancers
Current Medicinal Chemistry Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Current Medicinal Chemistry Tau Therapeutic Strategies for the Treatment of Alzheimers Disease
Current Topics in Medicinal Chemistry Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry SiO2 NPs: Promising Candidates for Drug and Gene Delivery
Drug Delivery Letters Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Na<sup>+</sup>/K<sup>+</sup> ATPase Inhibitors in Cancer
Current Drug Targets The DREAM of Pain Relief
Current Rheumatology Reviews The Other Side of Opioid Receptor Signalling: Regulation by Protein-Protein Interaction
Current Drug Targets <i>Piper sarmentosum</i> Roxb. Attenuates Beta Amyloid (Aβ)-Induced Neurotoxicity <i>Via</i> the Inhibition of Amyloidogenesis and Tau Hyperphosphorylation in SH-SY5Y Cells
Current Alzheimer Research Potential Medications or Compounds Acting on Toll-like Receptors in Cerebral Ischemia
Current Neuropharmacology Hesperetin Liposomes for Cancer Therapy
Current Drug Delivery HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity
Current HIV Research The Current Chemical Utility of Marine and Terrestrial Filamentous Fungi in Side-Chain Chemistry
Current Organic Chemistry Multifaceted Role of Neuropilins in Cancer
Current Medicinal Chemistry The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry